Answers are grounded in this paper and cite their sources.
Neuropathic pain component occurs in every second patient with pain syndrome caused by a malignant tumor. Detection of the neuropathic component of pain syndrome is crucial for selection of effective analgesia. The review presents an application algorithm for an updated system of neuropathic pain component assessment in oncological patients.
No takes yet. Share an insight, caveat, or question.
Spasova et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: